Study of Patritumab Deruxtecan in Participants with Gastrointestinal Cancers (MK-1022-011)

Trial Identifier: 1022-011
Sponsor: MSD
Collaborator:
Daiichi Sankyo
Start Date: November 2024
Primary Completion Date: July 2028
Study Completion Date: July 2028
Condition: Gastric Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Protocol Plain Language Summary - English

Trial Locations

Country Location
Israel, N/A Haifa, N/A, Israel, 3109601
Israel, N/A Tel Aviv, N/A, Israel, 6423906
Israel, N/A Yerushalayim, N/A, Israel, 9112001
Korea, Republic of, Seoul Seoul, Korea, Republic of, 05505
Korea, Republic of, Seoul Seoul, Korea, Republic of, 03080
Taiwan, Taipei Taipei, Taiwan, 10002
United States, GA Marietta, GA, United States, 30060